BioNTech SE

NASDAQ:BNTX

Biotechnology

Healthcare
$83.26 -1.52%

-$1.41 today

Market cap
$20.64B
Beta
1.32
P/E (TTM)
-16.2
EPS (TTM)
-$4.93
52W Low $79.52High $124.00

Volume 1.24M

Average 1.11M

BNTX Interest Income

Income earned on cash, deposits, and investments held by the company.

BioNTech SENASDAQ: BNTX

Interest Income · Q2 FY2026 · quarter ended Jun 2026

Interest income remains negative

Q2 FY2026 interest income was €97.3M, compared with €0 a year earlier. Trailing-twelve-month interest income was €420.15M. Over 3 fiscal years it compounded at +74.6% a year.

Context

  • Interest income amounted to 9.2% of revenue in FY2025, up 9.2 pp from a year earlier.
  • Interest income increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly interest income holds near €97.3M or moves back toward the trailing-twelve-month quarterly average of €105.04M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
€97.3M+55.1% QoQ
Last fiscal yearDec 2025
€252.24M— YoY
LTMJun 2026
€420.15M— YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR+74.6%——
5-year CAGR——
10-year CAGR——

Interest Income history

EUR · from the income statement

Latest · FY2025
252.24M EUR
Year-over-year change
—
4-year CAGR
+256.4%

Interest Income vs competitors

How BNTX compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Interest income amounts to 15.9% of revenue for BNTX, versus a peer median of 3.7%.
BNTX Competitors
Interest Income for BNTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BNTXBioNTech SELTM Jun 2026€420.15M EUR—+74.6%15.9%
GMABGenmab A/SLTM Jun 2026$129.91M USD—-24.7%3.1%
INCYIncyte CorporationLTM Jun 2026$129.34M USD+86.7%—2.2%
XNCRXencor, Inc.LTM Jun 2026$23M USD-24.6%+78.8%21.9%
IMTXImmatics N.V.LTM Mar 2026€15.3M EUR-36.7%+90.7%41.0%
IMCRImmunocore Holdings plcLTM Mar 2026$14.94M USD-30.5%+63.7%3.9%
IBRXImmunityBio, Inc.LTM Sep 2026$11.91M USD+183.5%+35.2%6.5%
IOVAIovance Biotherapeutics, Inc.LTM Sep 2026$8.6M USD-52.6%+51.1%2.3%
MGNXMacroGenics, Inc.LTM Mar 2026$5.93M USD-29.4%+26.0%3.8%
CGENCompugen Ltd.LTM Mar 2026$2.66M USD-49.0%+45.3%3.7%
TGTXTG Therapeutics, Inc.LTM Sep 2026$0 USD——0.0%
Peer median (excluding BNTX) —-30.0%+48.2%3.7%

Competitors are the stored peer set for BNTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue18.98B17.31B3.82B2.75B2.76B
Cost of Revenue2.91B3B599.8M541.3M616.47M
Gross Profit16.07B14.32B3.22B2.21B2.14B
Gross Margin84.7%82.7%84.3%80.3%77.6%
Research & Development949.2M1.54B1.78B2.25B2.02B
Selling, General & Admin327.2M541.2M557.7M599M698.2M
Operating Expenses781.4M1.67B2.53B3.52B2.76B
Depreciation & Amortization75.2M123.3M183.4M298M367.69M
EBITDA15B13.1B1.38B(367.1M)(628M)
EBITDA Margin79.1%75.7%36.1%-13.3%-22.8%
Operating Income15.28B12.64B690.4M(1.31B)(623.87M)
Operating Margin80.5%73.0%18.1%-47.8%-22.6%
Interest Income1.56M47.37M351.31M0252.24M
Interest Expense5.63M15.82M7.76M13.16M13.64M
Other Income / Expenses(237.4M)311.4M495.7M636.6M(385.46M)
Income Before Tax15.05B12.95B1.19B(677.7M)(1.01B)
Pre-Tax Margin79.3%74.8%31.1%-24.6%-36.6%
Income Tax Expense4.75B3.52B255.8M(12.4M)81.93M
Net Income10.29B9.43B930.3M(665.3M)(1.09B)
Net Margin54.2%54.5%24.4%-24.2%-39.6%
EPS (Basic)43.8738.083.87(2.77)(4.51)
EPS (Diluted)41.2137.093.83(2.77)(4.51)
Weighted Avg Shares244M243.3M240.6M240.4M241.7M
Weighted Avg Shares (Diluted)259.7M249.8M242.7M240.4M241.7M

BioNTech SE

NASDAQ:BNTX

Intrinsic Alpha fair value

Locked

Current Price

$83.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.